This is a drug monograph from the BSAVA Small Animal Formulary Part A: Canine and Feline. BSAVA members should login for access to the full monograph. Non-members can join BSAVA, buy a Formulary subscription, or buy the printed edition.
García San José P, Arenas Bermejo C, Alonso-Miguel D et al. (2022) Survival of dogs with pituitary-dependent hyperadrenocorticism treated twice daily with low doses of trilostane.Veterinary Record191, e1630
Lemetayer J and Blois S (2018) Update on the use of trilostane in dogs. The Canadian Veterinary Journal59, 397–407
Mellett Keith A, Bruyette D and Stanley S (2013) Trilostane therapy for treatment of spontaneous hyperadrenocorticism in cats: 15 cases (2004–2012).Journal of Veterinary Internal Medicine 27, 1471–1477
Macfarlane L, Parkin T and Ramsey I (2016) Pre-trilostane and three-hour post-trilostane cortisol to monitor trilostane therapy in dogs.
Veterinary Record179,597
Sanders K, Kooistra HS and Galac S (2018) Treating canine Cushing’s syndrome: current options and future prospects.The Veterinary Journal241, 42–51
Crosby J and Brown S (2017) Stability of compounded trilostane suspension in cod liver oil.The Veterinary Journal228, 15–17
RamseyI (2010)Trilostane: a review.Veterinary Clinics of North America: Small Animal Practice40,269–283
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
